104 10055 17 (02)2391-9529 http://www.publichealth.org.tw/ 104 5 28

... 3... 4... 4... 10... 11... 11... 12

the Association of Schools of Public Health, ASPH 35-40 2007 4 ASPH ASPH - 3 -

100 60-4 -

(%) ( ) ( ) ( μ σ s ) ( ) ( 20% ) ( Bernoulli, Binomial) ( ) ( ) ( z t ) ( ) ( ) ( 30% p ) (μ ) ( ) ( z Student t paired t 30% ANOVA F Chi-square McNemar ) ( ) ( ) 20% ( ) - 5 -

( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) (%) 10% 10% 40% 20% 20% - 6 - (%) 10% ( ) ( 一 ) ( 二 ) ( 三 ) ( 四 ) ( 五 ) ( 六 ) I ( 一 ) ( 二 ) ( 三 ) II ( ) ( ) 30% 30% 30%

( ) ( ) ( ) (Recognition of Hazards) 1. 2. 3. 4. 5. 6. 7. 8. 9. (Evaluation of Hazards) 1. 2. 3. 4. 5. (Control of Hazards) 1. 2. 3. 4. 5. (%) 60% 40% - 7 -

( ) ( ) ( ) ( ) ( ) ( ) (from Alma Ata to Ottawa) ( ) ( ) ( ) ( ) ( PRECEDE-PROCEED) ( ) ( ) / / ( ) ( ) ( ) ( ) (%) 15% 35% 30% 20% - 8 -

Pagano, M., & Gauvreau, K. (2000). Principles of Biostatistics (2nd ed.). Duxbury Press. ( ) (2008) ( Kuzma, J. W., & Bohnenblust, S. (2000). Basic Statistics for the Health Sciences (5th ed.). McGraw-Hill.) Glantz, S. A. (2006). Primer of Biostatistics. McGraw Hill. Deniel, W. W. (2009). Biostatististices: A Foundation for Analysis in the Health Sciences. Wiley. (1999) Gordis, L. (2008). Epidemiology (4rd ed.). Elsevier. (2008) ( ) 98 103 http://www.publichealth.org.tw/ ( ) 1. (A) (process evaluation) (B) (outcome evaluation) (C) (impact evaluation) (D) (formative evaluation) ( ) 2. (A) (B) (C) (D) (E)(mesothelioma) - 9 -

( ) 3. (A) (stage of susceptibility) (B) (latent period) (C) (incubation period) (D) (stage of disability) 1 4 104 9 12 (A) (Primary Health Care) (B) (Secondary Health Care) (C) (Tertiary Health Care) (D) (Fourth Health Care) ( ) 1. (Accessibility) ( ) 2. ( ) 3. ( ) 4. 80 10 ( ) 20 ( ) 50 9 12 ( ) 08:30-09:50 10:10-11:30 12:30-13:50 14:10-15:30 15:50-17:10-10 -

( 17 ) ( 91 ) ( 100 ) (701 ) (http://www.publichealth.org.tw/) 104 6 11 6 30 ( ) 104 6 11 6 30 ( ) 10055 17 600 104 6 11 6 30 ( ) ( 01014920) ( ) ( ) ( ) ( ) - 11 -

- 12 -